In addition, more lymph node metastasis was observed in patients positive for both IGFBP2 and β-catenin proteins (18/24, 75%) compared with patients with low levels of both proteins (1/24, 4%) (p = 0.0006). This evidence concerns the gene IGFBP2 and metastatic malignant neoplasm in the lymph nodes.